Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Clinical use of selected and expanded peripheral blood CD34+ cells: a preliminary report of feasibility and safety.

Clinical use of selected and expanded peripheral blood CD34+ cells: a preliminary report of feasibility and safety. J Hematother. 1995 Dec; 4(6):527-9.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.